Identification of genes regulated by interleukin-1β in human endometrial stromal cells
article
OA: green
CC0
⤵ 20 in-corpus citations
Abstract
Interleukin-1beta (IL-1b) is an important immune regulatory factor that in human endometrium plays a role in both menstruation and implantation in the event of pregnancy. It promotes inflammatory-like processes and also stimulates tissue remodelling. We present a cDNA microarray study documenting the major effects of IL-1beta on gene expression in stromal cells from human endometrium. Endometrial stromal cells from five normal healthy women at the mid secretory phase were cultured with or without IL-1beta at 50 and 500 pg/ml for 48 h. cDNA microarrays were used to compare the levels of gene expression in total RNA isolated from cells stimulated with IL-1beta. These cDNA arrays were produced containing 15 164 sequence-verified clones, which included genes known to be important in angiogenesis, immune modulators, apoptosis, cell signalling, extra-cellular matrix (ECM) remodelling and cell cycle regulation. Genes which were regulated by IL-1beta were identified by analysis of the microarray data using the Significance Analysis of Microarrays software package. Upregulated (n = 23) and downregulated (n = 6) different genes were observed, which changed at least 3-fold, at a false discovery rate of less than 2% (P < 0.02). Our results have identified genes regulated by IL-1beta, which are involved in leukocyte recruitment, ECM remodelling and other cellular functions. Changes in three genes, IL-8, colony-stimulating factor 2 and aldoketo reductase family 1 member 1, which were upregulated by IL-1beta, were verified using real-time PCR. Novel functions regulated by IL-1beta in endometrium, including genes involved in free radical protection, and fatty acid metabolism were also identified. These results also provide new insights into the role of IL-1beta in disorders of the endometrium, especially in implantation-related infertility and endometriosis, in which this cytokine plays a major role.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses via openalex
- Immunobiology of endometriosis via openalex
- Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1 via openalex
- Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. via openalex
- W1928748468 via openalex
- W1967373897 via openalex
- W1970762272 via openalex
- W1980480613 via openalex
- W1983754168 via openalex
- W1994608570 via openalex
- W1995595423 via openalex
- W2009575988 via openalex
- W2015629565 via openalex
- W2017074373 via openalex
- W2024741835 via openalex
- W2026938634 via openalex
- W2044584737 via openalex
- W2047203711 via openalex
- W2049775789 via openalex
- W2058054201 via openalex
- W2065963344 via openalex
- W2067517632 via openalex
- W2074771496 via openalex
- W2097390476 via openalex
- W2106048402 via openalex
- W2106840700 via openalex
- W2113667637 via openalex
- W2120608514 via openalex
- W2121497709 via openalex
- W2130244292 via openalex
- W2134119264 via openalex
- W2155509621 via openalex
- W2157795344 via openalex
- W2163788820 via openalex
- W2166787544 via openalex
- W2167602854 via openalex
- W2168506792 via openalex
- W2176403835 via openalex
- W2204640292 via openalex
- W2259771768 via openalex
- W2301406109 via openalex
- W2408554838 via openalex
- W4235173854 via openalex
- W4246962518 via openalex
- W196233321 via openalex
- W4294107304 via openalex
- W1484450968 via openalex
- W1515994079 via openalex
- W1650752673 via openalex
Cited by (20)
- Exploring the link between serum uric acid and endometriosis: a cross-sectional analysis utilizing NHANES data from 1999-2006 2025
- ADAMS-1 and ADAMS-9, novel markers in endometriosis 2021
- Interleukin-1/-33 Signaling Pathways as Therapeutic Targets for Endometriosis 2019
- Seminal Plasma Promotes Lesion Development in a Xenograft Model of Endometriosis 2015
- Role of Iron in the Pathogenesis of Endometriosis 2015
- Molecular Evolution, Characterization and Expression Profiling of Uterine Aldoketoreductase 1B5 Gene in Endometrium of Goat (<i>Capra hircus</i>) 2014
- Cytokines and Endometriosis - the Role of Immunological Alterations 2013
- Endometriosis 2013
- Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases 2012
- New trends for the medical treatment of endometriosis 2012
- Decreased concentrations of soluble interleukin-1 receptor accessory protein levels in the peritoneal fluid of women with endometriosis 2011
- Distinct expression of the soluble and the membrane-bound forms of interleukin-1 receptor accessory protein in the endometrium of women with endometriosis 2011
- Endometriosis 2009
- ‘Blood On The Tracks’ from corpora lutea to endometriomas* 2009
- The role of iron in the pathogenesis of endometriosis 2009
- Development and evaluation of two mouse models for endometriosis focused on the involvement of the immune system in endometriosis establishment 2008
- Angiogenesis and antiangiogenic therapy in endometriosis 2007
- Oral eicosapentaenoic acid supplementation as possible therapy for endometriosis 2007
- Role of interleukin-1 receptor type II in the pathogenesis of endometriosis 2007
- Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium 2007
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:15:29.922408+00:00
License: CC0
· commercial use OK